Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
195.61B | 218.94B | 263.31B | 184.63B | 119.70B | Gross Profit |
25.06B | 31.25B | 81.64B | 52.46B | 19.95B | EBIT |
25.06B | 31.98B | 45.67B | 27.86B | -4.87B | EBITDA |
41.11B | 50.78B | 59.13B | 37.84B | 8.85B | Net Income Common Stockholders |
15.76B | 21.38B | 20.53B | 16.03B | -7.34B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
32.76B | 31.62B | 41.77B | 33.66B | 35.90B | Total Assets |
285.49B | 283.65B | 303.86B | 293.46B | 266.13B | Total Debt |
53.56B | 47.87B | 60.77B | 64.55B | 77.30B | Net Debt |
27.71B | 22.41B | 27.74B | 43.20B | 46.03B | Total Liabilities |
165.23B | 164.20B | 189.29B | 178.46B | 160.05B | Stockholders Equity |
117.86B | 116.75B | 111.72B | 111.74B | 103.70B |
Cash Flow | Free Cash Flow | |||
15.95B | 22.96B | 31.68B | 18.07B | 4.04B | Operating Cash Flow |
30.85B | 40.68B | 47.37B | 30.41B | 14.80B | Investing Cash Flow |
-17.33B | -16.45B | -15.12B | -13.66B | -13.08B | Financing Cash Flow |
-14.43B | -29.73B | -19.27B | -26.15B | 1.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $115.97B | 8.20 | 11.75% | 4.80% | -9.86% | -32.59% | |
75 Outperform | $236.91B | 13.95 | 11.28% | 4.84% | -1.90% | -14.56% | |
74 Outperform | $180.57B | 12.15 | 8.82% | 4.29% | -5.74% | -11.09% | |
73 Outperform | $447.19B | 13.19 | 14.38% | 3.67% | 1.86% | -11.52% | |
73 Outperform | $62.92B | 7.45 | 19.39% | 5.14% | -4.07% | -20.34% | |
62 Neutral | $68.32B | 186.20 | -1.87% | 6.66% | -7.70% | -113.83% | |
56 Neutral | $6.99B | 3.72 | -4.39% | 5.96% | -0.24% | -48.44% |